Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New research project about the genetic modification of cancer cells

21.03.2014

Better understanding of the generation of leukaemias

Tumour cells shut down certain genes in the course of the progressing degeneration or mutate these, a process that considerably accelerates the growth of the tumour.


Extract from the structure of the Dnmt3a DNA methyl transferase (red, blue and cyan) with DNA (green). The positions of mutations in tumours are represented by red and orange balls.

Illustration: University of Stuttgart

An important role in this process is played by epigenetic factors and thereby in particular DNA methyl transferase (Dnmts), i.e. enzymes that transmit methyl groups on nucleic bases of the DNA. A research group at the Chair for Biochemistry at the University of Stuttgart (Head Prof. Albert Jeltsch) is now investigating in a new project the influence of mutations in the DNA methyl transferase Dnmt3a, that are observed in many leukaemias. The scientists want to elucidate how these modifications contribute towards cancer developing. 

The fact that tumour cells shut down or mutate in the course of progressing degeneration has been known for years. Traditionally so-called tumour suppressor genes are affected by this process, that prevent cells with damages in the genome dividing and ultimately drive these cells to a controlled cell death.

However, genes are also frequently damaged or shut down, whose products are involved in the repair of DNA damages. The loss of these factors leads to an increase in mutations in the affected cells, promoting the further progression of tumours. 

The rapid development of DNA sequencing technologies has, among other things, led to the identification of many additional mutations in tumour cells. A better understanding of these somatic mutations can help to better understand the process of the tumour developing and to develop targeted therapies for defined sub-types of tumours. A new group of somatically mutated genes are so-called “epigenetic“ factors.

These factors control how strongly genes are transcribed and ultimately through this regulate how the information of the genome is implemented. This group also includes DNA methyl transferase that transmits the methyl groups to the DNA and plays a decisive role in the development of human cells.

It was recently shown that the DNA methyl transferase Dnmt3a is a focal point of somatic tumour mutations in many leukaemias. In this way, up to 30 percent of the patients show a certain mutation in the Dnmt3a gene in a sub-group of leukaemias. This mutation brings about the targeted exchange of an amino acid into another in the protein, comprising a total of 912 amino acids. 

Building on its 10 years of experience in investigating Dnmt3a, the workgroup Jeltsch is planning to investigate the effects of these and other tumour mutations in Dnmt3a in the project financed by the German Research Association DFG with the focus on the “Epigenetic Regulation of the normal haematopoiesis and its dysregulation in myeloid neoplasia“.

The results of this project will help to elucidate the tumour-inducing effect of somatic Dnmt3a tumour mutations and to understand how the modifications in the DNA methylation lead to cancer.

Further information:
Prof. Albert Jeltsch, University of Stuttgart, Chair for Biochemistry, 0711/685-64390
Email albert.jeltsch (at) ibc.uni-stuttgart.de
Andrea Mayer-Grenu, University of Stuttgart, Department of University Communication, Tel. 0711/685-82176,
Email: andrea.mayer-grenu (at) hkom.uni-stuttgart.de

Andrea Mayer-Grenu | Universität Stuttgart

Further reports about: Biochemistry DNA amino developing genes methyl modification modifications mutate mutations somatic tumour tumours

More articles from Life Sciences:

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Predicting unpredictability: Information theory offers new way to read ice cores

07.12.2016 | Earth Sciences

Sea ice hit record lows in November

07.12.2016 | Earth Sciences

New material could lead to erasable and rewriteable optical chips

07.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>